Tag: squamous cell cancer

1. Nivolumab significantly increased median overall survival in patients with platinum refractory relapsed metastatic head and neck squamous cell carcinoma (SCC) compared to standard therapy. 2. Compared with standard chemotherapy options, nivolumab was associated with fewer grade 3 or 4 adverse effects and a higher patient-reported quality of life. Evidence Rating...
1. Compared to HPV negative oropharyngeal squamous cell carcinoma, HPV positive tumors are associated with increased overall survival after progression of disease. Evidence Rating Level: 2 (Good) Study Rundown: Certain strains of human papillomavirus (HPV) are associated with oropharyngeal squamous cell carcinomas (OPCs), and HPV positive tumors have significantly reduced risk...